Tools and resources
The target audience for these guidelines is district-level implementation agencies that are concerned with achieving their targets for mass drug administration. The purpose of these guidelines is to introduce the following.
• The concept of narratives and how they can be a valuable tool in understanding people’s health behaviors in the context of NTD control and elimination as well as in other programs;
This page describes a call for proposals which has since closed. Please refer back to this page for updates.
The Supervisor's Coverage Tool (SCT) is a rapid in-process monitoring tool designed to improve coverage during the current round of mass drug administration within a given supervisory area. The SCT has also been shown to be a useful supervisory tool for first-level supervisors and community drug distributors.
The Onchocerciasis IgG4 test is a rapid diagnostic test that qualitatively detects IgG4 antibodies against the Ov16 antigen in human blood samples. This guide will demonstrate how to use and interpret the test. Although the test is relatively simple to use, adequate training is necessary to reduce inter-observer variability and interpretation error.
This is a modifiable example of a paper-based questionnaire for conducting Post-MDA Coverage Surveys.
Partners in the national, international, academic, industrial and philanthropic sectors work together to develop new technologies in the fight to control and eliminate neglected tropical diseases. Click on the links to the right to view infographics on the Alere Filaraisis Test Strip, the Ov16 Rapid Diagnostic Test, the Wb123 Rapid Diagnostic Test, the Ov16/Wb123 Biplex and the Pgp3 Lateral Flow Assay. Team members are listed in alphabetical order.
The Brugia Rapid test has been shown to be a useful and sensitive tool for the detection of Brugia malayi and Brugia timori antibodies and is being used widely by lymphatic filariasis elimination programs in Brugia spp. endemic areas. Although the test is relatively simple to use, adequate training is necessary to reduce inter-observer variability and to reduce the misreading of cassettes.
In the event of a failed TAS result, this tool can be used to determine how many individuals need to be retested in order to confirm that the number of true positive results is above the critical cut-off for TAS.
This training video demonstrates how to use the Alere Filariasis Test Strip (FTS), a diagnostic test for detecting antigens present in the blood of people with lymphatic filariasis. With funding from the Bill and Melinda gates Foundation (BMGF) in collaboration with many partners – including RTI, the U.S. Centers for Disease Control and Prevention (CDC), Washington University School of Medicine in St.